OPHTHALMIC PHOTOCOAGULATION LASERS MARKET

INTRODUCTION

An eye laser procedure is called laser photocoagulation. Treatment for age-related macular degeneration is administered (AMD). A disorder called AMD can cause visual loss. The layer of cells in the back of your eye called the retina is responsible for converting light into electrical messages.

Laser photocoagulation is used to lower the risk of diabetic retinopathy-related visual loss. Instead of restoring eyesight that has already been lost, it is most frequently used to maintain vision and stop further visual loss.

The eye may experience some soreness. If necessary, find out if you are able to use over-the-counter painkillers. If you have eye discomfort, redness, or swelling, let your ophthalmologist know. Following laser photocoagulation, some hazy vision is typical.

Laser photocoagulation is quite secure. You may anticipate going home the same day because it is an outpatient treatment. In order to make the procedure comfortable, your doctor will numb the eye using medicinal drops and an injection of local anaesthetic.

OPHTHALMIC PHOTOCOAGULATION LASERS MARKET SIZE AND FORECAST

The Global Ophthalmic Photocoagulation lasers market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

OPHTHALMIC PHOTOCOAGULATION LASERS MARKETRECENT DEVELOPMENT

Endophotocoagulation is a technique used during pars plana surgeries such as vitrectomies and the treatment of proliferative diabetic retinopathy. Argon green or a diode laser are delivered via fibre optical cable. 

The first medical use of lasers was for retinal photocoagulation, and that function has been changing over time. Today, its use as a diagnostic and therapeutic tool is obvious in all subspecialties of ophthalmology.

Photocoagulation: When a target tissue absorbs a laser beam, the temperature rises, which causes the denaturation of proteins. For instance, argon, krypton, the 810 Diode, and the frequency-doubled ND: YAG laser.

Unrecorded early research into therapeutic photocoagulation was conducted. Photic burns might be useful as a form of therapy. The main drawback of this was the need for sufficient sunlight to produce the desired result.

As a result, non-solar light sources like Carbon arcs and Zeiss' Xenon arc photocoagulators began to develop. Mainman and colleagues created the first functional LASER.

OPHTHALMIC PHOTOCOAGULATION LASERS MARKETNEW PRODUCT LAUNCH

At the World Ophthalmology Congress, ZEISS announced the next generation of ophthalmic laser VISULAS green. The next generation of ZEISS photocoagulation laser, VISULAS green, allows doctors to completely focus on the patient's treatment procedure without interruption.

At the World Ophthalmology Congress in Barcelona today, the ZEISS Medical Technology business group introduced its next-generation VISULAS green photocoagulation laser. Retinal Photocoagulation Lasers are used to treat a wide range of eye illnesses, including two of the leading causes of blindness: diabetic retinopathy and age-related macular degeneration.

VISULAS green allows clinicians to monitor critical treatment settings directly from the eyepiece and adjust these parameters while using the joystick, allowing for uninterrupted productivity.

Not only is VISULAS green assisting doctors in the treatment of retinal illnesses and glaucoma, but it is also speeding up their regular clinical routine experience. With an uninterrupted workflow, clinicians may operate more efficiently and keep their concentration on the patient."

ZEISS VISULAS green provides a well-organized user interface, allowing the doctor to completely focus on their patient." The integrated data management system provides user-specific treatment methods as well as a contact lens database for many users.

ZEISS VISULAS green is a modular and expandable laser workstation that comes in a traditional and a comfort form and with a choice of single or twin fibre connectors.

To minimize treatment durations, the comfort model can be upgraded to accommodate multi-spot photocoagulation with the ZEISS VITE option. Immediately following the process, VISULAS green presents the automatic treatment parameter summary.

To develop a paperless laser treatment record, the treatment summaries can be exported into ZEISS FORUM, the company's eye care data management system.

ZEISS is dedicated to advancing eye care by connecting patient data at every stage of the process.The company provides innovative technologies and application-oriented solutions to help doctors improve the quality of life of their patients. The company provides comprehensive solutions for diagnosing and treating eye problems, including implants and consumables.

OPHTHALMIC PHOTOCOAGULATION LASERS MARKETCOMPANY PROFILE

• A.R.C
• Ellex Medical
• Lumenis
• Nidek
• Norlase

THIS REPORT WILL ANSWER FOLLOWING QUESTIONS OFOPHTHALMIC PHOTOCOAGULATION LASERS MARKET

1. How many Ophthalmic Photocoagulation lasers are manufactured per annum globally? Who are the sub-component suppliers in different regions?
2. Cost breakup of a  Global Ophthalmic Photocoagulation lasers and key vendor selection criteria
3. Where is the Ophthalmic Photocoagulation lasers manufactured? What is the average margin per unit?
4. Market share of Global Ophthalmic Photocoagulation lasers market  manufacturers and their upcoming products
5. Cost advantage for OEMs who manufacture Global Ophthalmic Photocoagulation lasers in-house
6. key predictions for next 5 years in Global Ophthalmic Photocoagulation lasers market
7. Average B-2-B Ophthalmic Photocoagulation lasers market price in all segments
8. Latest trends in Ophthalmic Photocoagulation lasers market, by every market segment
9. The market size (both volume and value) of the Ophthalmic Photocoagulation lasers market in 2023-2030 and every year in between?
10. Production breakup of Ophthalmic Photocoagulation lasers market, by suppliers and their OEM relationship